Corporate Compass
Strategy, M&A and geopolitical pressures on global firms.
How FDA’s Prior-Knowledge Strategy Is Reshaping Global Cell and Gene Therapy Development
The FDA's new draft guidance allowing developers to use prior knowledge could accelerate cell and gene therapy development, with profound implications for global biotech investment, regulatory convergence, and international competitiveness.
Business Leaders Forge Ahead in 2026 as Global Confidence Fragments
J.P. Morgan survey reveals a widening gap between cautious macro outlook and firm-level confidence, as AI and tariffs reshape corporate strategy worldwide.
How Policy Choices Cost Europe Its Biopharma Leadership: Lessons for the Global Innovation Race
An analytical piece on how Europe's biopharma decline due to price controls and restrictive policies reshaped global innovation, offering lessons for the United States and other nations competing in life sciences R&D.
FDA's Prior Knowledge Guidance Reshapes Global Cell and Gene Therapy Landscape
The FDA's new draft guidance on prior knowledge and platform knowledge promises to accelerate cell and gene therapy development, with significant global economic, investment, and regulatory implications.
Global Business Leaders Forge Ahead in 2026 with Cautious Optimism
The J.P. Morgan 2026 Business Leaders Outlook reveals stabilizing sentiment, with leaders focusing on their own performance despite global uncertainty. Explore how AI, tariffs, and economic policy shape international strategy.
Why the Hand Compass Market Is Navigating Global Industry Shifts
The hand compass market, valued at USD 150.5 million in 2026, is projected to grow to USD 207.8 million by 2033. This analysis examines the industry's global expansion, technological evolution, and strategic significance across defense, outdoor recreation, and maritime navigation.